Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study. [electronic resource]
- BMC neurology Nov 2018
- 186 p. digital
Publication Type: Journal Article; Multicenter Study
1471-2377
10.1186/s12883-018-1179-0 doi
Adolescent Adult Aged Persons with Disabilities Disease Progression Female Greece Humans Interferon beta-1a--therapeutic use Male Middle Aged Multiple Sclerosis, Relapsing-Remitting--drug therapy Prospective Studies Seasons Young Adult